Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 44INDUSTRY 23NIH 15OTHER_GOV 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 10Lung Neoplasms 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 7Adenocarcinoma of Lung 7Colonic Neoplasms 5Adenocarcinoma, Bronchiolo-Alveolar 4Glioblastoma 3Brain Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Inflammatory Breast Neoplasms 2Gliosarcoma 2Carcinoma 2Breast Neoplasms, Male 2Unspecified Adult Solid Tumor, Protocol Specific 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Oligodendroglioma 1Non Small Cell Lung Cancer Metastatic 1Meningioma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Glioma 1Fallopian Tube Neoplasms 1Erythema Multiforme 1Ependymoma 1Cognition Disorders 1

Interventions

Paclitaxel 15Carboplatin 15Taxes 9Cisplatin 8Topotecan 4Docetaxel 4Filgrastim 3pegfilgrastim 2paclitaxel poliglumex 2liposomal doxorubicin 2Methods 2Gemcitabine 2GEN-1 2Etoposide 2Erlotinib Hydrochloride 2Educational Status 2Early Intervention, Educational 2Chemotherapy, Adjuvant 2vandetanib 1rilotumumab 1oregovomab 1motesanib diphosphate 1elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Watchful Waiting 1VTX-2337 1Trabectedin 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Fallopian Tube Neoplasms × Bevacizumab × Clear all
NCT00886691 2022-02-04

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

GOG Foundation

Phase 2 Completed
150 enrolled 11 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡